高等学校化学学报

• 研究论文 • 上一篇    下一篇

界面聚合法制备PANI/TiO2纳米复合纤维材料

佟永纯1,2, 胡常林1, 王清云1, 白洁1, 雷自强1, 苏碧桃1   

    1. 西北师范大学化学化工学院, 甘肃省高分子材料重点实验室, 省部共建生态环境相关高分子材料教育部重点实验室, 兰州 730070;
    2. 河西学院化学系, 张掖 734000
  • 收稿日期:2007-07-27 修回日期:1900-01-01 出版日期:2008-02-10 发布日期:2008-02-10
  • 通讯作者: 苏碧桃

Preparation of PANI/TiO2 Composite Nanofiber Materials by Interfacial Polymerization

TONG Yong-Chun1,2, HU Chang-Lin1, WANG Qing-Yun1, BAI Jie1, LEI Zi-Qiang1, SU Bi-Tao1*   

    1. Key Laboratory of Eco-Environment-Related Polymer Materials, Ministry of Education, Key Laboratory of Polymer Materials of Gansu Prouince, College of Chemistry and Chemical Engineering, Northwest Normal University, Lanzhou 730070, China;
    2. Department of Chemistry, Hexi University, Zhangye 734000, China
  • Received:2007-07-27 Revised:1900-01-01 Online:2008-02-10 Published:2008-02-10
  • Contact: SU Bi-Tao

摘要: 采用界面自组装聚合的方法, 成功地制备出PANI/TiO2纳米复合纤维材料, 采用TEM, FTIR, XRD及TG等技术对其形貌、结构及热稳定性能进行了表征, 并考察了苯胺单体浓度、TiO2的活化与否对复合材料形貌的影响. 结果表明, TiO2的活化处理是影响该复合材料形貌的主要因素, 活化处理后的TiO2能进入PANI纳米纤维的内部, 且分散得更加均匀; PANI/TiO2纳米复合纤维的直径随着苯胺单体浓度的增加而增加. 同时, TiO2的加入改善了PANI的耐热性能. 采用该法合成的纳米复合材料具有合成条件温和、易于控制、纯化简单、省去了使用模板/消除模板的过程及能够一步得到大量产品等许多优点.

关键词: PANI/TiO2, 纳米复合纤维, 界面聚合

Abstract: PANI/TiO2 composite nanofibers were successfully synthesized by interfacial polymerization(IP). TEM, FTIR, XRD and TG were used to characterize the composite materials with regard to their morphologies, structures and thermal stability. The effects of the monomer concentration and the active treatment of TiO2 on the morphologies of the composite materials were investigated. The results show that TiO2 nanoparticles were inserted into the nanofibers and are more homogeneously dispersed in the PANI nanofibers and the stability of PANI was improved. For the interfacial self-assemble polymerization, its conditions are mild without employing/removing template approach and the product is easy to be handled and the yield is high.

Key words: PANI/TiO2, Composite nanofiber material, Interfacial polymerization

中图分类号: 

TrendMD: